4 mg tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide Dose Chart: 2.5 to

Activation of this pathway increases the cells ability to neutralize ROS before they can damage proteins, lipids, or DNA

It helps lower blood glucose by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and reducing appetite

The copper peptide at the centre of skin-renewal research, at over 99% purity studied for firmer, smoother, more radiant skin and scalp / follicle biology

Notably, Brusatol, a natural NRF2 inhibitor, enhances the binding of KEAP1 to NRF2, promotes NRF2 ubiquitination, and accelerates its proteasomal degradation, thereby suppressing NRF2-driven antioxidant function and sensitizing cancer cells to oxidative stress